In January 2024, Proxiad SEE launched a new subsidiary, Proxiad Health Tech. A team of IT specialists and biomedical engineers is already working on various projects in the healthcare sector. The company’s goals for this year include attracting new customers and further expanding its expertise and teams in this field.
Q: Why did Proxiad decide to develop in the health sector, and how did the creation of Proxiad Health Tech come about?
Alexander Milev: In recent years, healthcare has undergone significant digitalization. New technologies and artificial intelligence have advanced the sector, leading to numerous products and innovations. Partnerships with several clients in the field have allowed us to closely observe the latest trends in medicine and acquire niche knowledge. The growing need for such expertise has led us to expand our current activities and take the next step by creating a specialized company focused on these needs. We have thus created Proxiad Health Tech in early 2024.
Q: How does Proxiad Health Tech work and what will be the company’s main activities?
Alexander Milev: Proxiad Health Tech covers five key elements that provide comprehensive services to healthcare companies: long-standing expertise in software product development; qualified specialists with combined technical and medical training; professional experience with medical devices; strong knowledge of the healthcare sector and certification to work and market medical equipment. This positions us as one of the few companies to offer a combination of all of these activities in one place.
Q: How many and what kind of people work at Proxiad Health Tech? What are your plans to expand the team by the end of the year?
Alexander Milev: Our current team consists of over 45 professionals with extensive expertise, serving various departments and divisions of our clients. Roles include Biomedical Engineers, Validation & Verification Engineers, Angular, ReactJS, .NET, C++, Java, Full Stack Developers, QA, Azure Cloud Ops, DevOps, UI/UX Designers, Technical Leads, and Delivery Managers. This experience allows us to provide specialized services and address specific market needs.
By the end of the year, we plan to expand the team by 20%, through a combination of growth in our existing projects and the launch of new initiatives with companies in the sector. As a newly established company, we will also focus on positioning the new brand through various marketing initiatives in Europe and North America.
Q: Are there enough well-trained biomedical engineers? How do you plan to meet future needs?
Alexander Milev: We have a sufficient number of well-trained biomedical engineers to meet the needs of our organization and our customers. On a larger scale, the availability of this expertise is limited as it is a very specialized field. This is one of the roles that gives us a competitive advantage in the market. For this reason, we are planning to organize an academy to develop these talents internally within the organization.
Q: What are the first projects that Proxiad Health Tech has already implemented or is planning to start?
Alexander Milev: The projects we work on in the Health Tech sector are very interesting, and what motivates us the most is their significant impact on people’s health.
One of the projects is to simplify the large flow of medical data, helping healthcare professionals obtain meaningful and aggregated information. This includes the development of communication drivers for medical devices, data flow analysis solutions and testing of communication modules.
Another project aims to improve clinical supervision by ensuring real-time monitoring in various health establishments. It integrates detailed data from all connected devices, providing a comprehensive view of patient status and personalized notifications. This plays a crucial role in overcoming overload in complex hospital environments by providing care teams with reliable and timely patient indicators during transport, enabling informed decisions to be made.
We are also working on the management of medical data collected from various medical devices attached to patients in hundreds of hospitals. Our teams have created a module responsible for processing this data, aiming to improve patient care, increase hospital efficiency and help healthcare providers access critical medical information in real time. All development and testing of the equipment is carried out in Proxiad SEE offices.
Another key aspect is that we are a certified Qlik partner. We develop sophisticated yet user-friendly visual tools to enable pharmaceutical companies to monitor the effectiveness of their medical representatives’ sales force.
Q: Are you planning to expand your activities to new projects and clients, and in what areas?
Alexander Milev: This is the primary objective of creating Proxiad Health Tech. Our strategy is to continue to build on our existing expertise in various technology areas of the healthcare and pharmaceutical industries. We will maintain a strong focus on medical devices and data processing, telemedicine, digital tools that process health information securely, digital platforms including medical solutions and services, and data processing and analysis. health data.
Q: What are Proxiad Health Tech’s long-term development plans?
Alexander Milev: Our long-term goals are to make Proxiad Health Tech a hub with comprehensive expertise in the healthcare sector, providing comprehensive and integrated services that meet the individual needs of companies in the sector. We are ready to take on the challenges ahead and create partnerships that lay the foundation for new products and innovative solutions.
